Value Hunters: Look To Abbott Laboratories (ABT)

Currently, there are 1.73B common shares owned by the public and among those 1.72B shares have been available to trade. The company’s stock has a 5-day price change of 3.18% and -0.93% over the past three months. ABT shares are trading 3.25% year to date (YTD), with the 12-month market performance up to 2.43% higher. […]

Abbott Laboratories (ABT): Not A Time To Panic Nor Freeze

Abbott Laboratories (ABT) concluded trading on Wednesday at a closing price of $111.10, with 6.54 million shares of worth about $726.38 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 8.16% during that period and on January 15, 2025 the price saw a loss […]

Analysts Update Their Price Forecasts For Abbott Laboratories (ABT)

Abbott Laboratories (ABT) concluded trading on Thursday at a closing price of $113.44, with 3.56 million shares of worth about $404.09 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 10.86% during that period and on Thursday the price saw a gain of about […]

Investors Should Take Note Of Abbott Laboratories (ABT)

Abbott Laboratories (ABT) concluded trading on Thursday at a closing price of $115.27, with 2.96 million shares of worth about $340.95 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 10.15% during that period and on December 26, 2024 the price saw a gain […]

Look At Analyst Expectations For A Better Read On Abbott Laboratories (NYSE: ABT)

Currently, there are 1.73B common shares owned by the public and among those 1.72B shares have been available to trade. The company’s stock has a 5-day price change of -1.91% and -1.38% over the past three months. ABT shares are trading 2.93% year to date (YTD), with the 12-month market performance up to 5.59% higher. […]

Abbott Laboratories (NYSE: ABT) Stock In Prove Me State

Abbott Laboratories (ABT) concluded trading on Wednesday at a closing price of $114.14, with 4.74 million shares of worth about $541.25 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 9.35% during that period and on December 11, 2024 the price saw a loss […]

Value Hunters: Look To Abbott Laboratories (ABT)

Currently, there are 1.73B common shares owned by the public and among those 1.72B shares have been available to trade. Insiders at the company have transacted a total of 73 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 20 of these insider trades were purchases, […]

An Important Check-Up On Abbott Laboratories (NYSE: ABT)

Abbott Laboratories (ABT) concluded trading on Wednesday at a closing price of $112.06, with 3.99 million shares of worth about $447.23 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 6.78% during that period and on Wednesday the price saw a gain of about […]

Abbott Laboratories (NYSE: ABT): Stock That Needs Special Handling

Currently, there are 1.74B common shares owned by the public and among those 1.72B shares have been available to trade. Insiders at the company have transacted a total of 94 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 39 of these insider trades were purchases, […]

Abbott Laboratories (ABT) Testing Investors’ Patience Right Now

BlackRock Fund Advisors recently announced the acquisition of new stake in Abbott Laboratories (NYSE:ABT). The institutional investor has increased its shareholding in the Healthcare company by 1.96% to 89.35 million shares with purchase of 1.72 million shares. This fresh investment now brings its stake to 5.15% valued currently at $9.83 billion. In addition, Capital Research […]